Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT01855750
Brief Title: A Study of the Bruton's Tyrosine Kinase Inhibitor, PCI-32765 (Ibrutinib), in Combination With Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Patients With Newly Diagnosed Non-Germinal Center B-Cell Subtype of Diffuse Large B-Cell Lymphoma

First Submitted : May 14, 2013
First Submitted that Met QC Criteria : May 14, 2013
First Posted : May 16, 2013 (Estimate)

Results First Submitted : February 22, 2019
Results First Submitted that Met QC Criteria : February 22, 2019
Results First Posted : March 19, 2019

Last Update Submitted that Met QC Criteria : March 30, 2020
Last Update Posted : April 13, 2020